{"created":"2021-03-01T06:10:37.299451+00:00","id":6699,"links":{},"metadata":{"_buckets":{"deposit":"a16ab01c-2897-4eb7-a3c8-ca1dc7f9b932"},"_deposit":{"id":"6699","owners":[],"pid":{"revision_id":0,"type":"depid","value":"6699"},"status":"published"},"_oai":{"id":"oai:niigata-u.repo.nii.ac.jp:00006699","sets":["453:456","471:537:568:662"]},"item_7_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1985-12","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"3","bibliographicPageEnd":"132","bibliographicPageStart":"123","bibliographicVolumeNumber":"33","bibliographic_titles":[{"bibliographic_title":"Acta medica et biologica"},{"bibliographic_title":"Acta medica et biologica","bibliographic_titleLang":"en"}]}]},"item_7_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"The authors investigated the antiplatelet effects of the therapy combining DZP and ASA in five patients with occlusive cerebrovascular disorders and two normal subjects. The results were as follows: (1) The combination therapy of 100 mg ASA and 150 mg DZP showed stronger antiplatelet effects as compared with the sole therapy of 100 mg ASA, and when 30 mg ASA with 100 mg DZP were used 3 times per day, thoroughly satisfactory antiplatelet effects were also obtained. (2) An effective antithrombotic therapy using the combination of 30 mg ASA and 100 mg DZP, 3 times per day for patients with cerebral infarction and transient ischemic attack can be expected. (3) By reducing the ASA dose, we can avoid gastrointestinal disorders.","subitem_description_type":"Abstract"}]},"item_7_publisher_7":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Niigata University School of Medicine"}]},"item_7_select_19":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_select_item":"publisher"}]},"item_7_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AA00508361","subitem_source_identifier_type":"NCID"}]},"item_7_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"05677734","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Arai, Hiroyuki"}],"nameIdentifiers":[{"nameIdentifier":"53985","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Miyakawa, Teruo"}],"nameIdentifiers":[{"nameIdentifier":"53986","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Sekine, Hitoshi"}],"nameIdentifiers":[{"nameIdentifier":"53987","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Sato, Shinji"}],"nameIdentifiers":[{"nameIdentifier":"53988","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Kondo, Shin-ichi"}],"nameIdentifiers":[{"nameIdentifier":"53989","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Takahashi, Kaoru"}],"nameIdentifiers":[{"nameIdentifier":"53990","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Sakuragawa, Nobuo"}],"nameIdentifiers":[{"nameIdentifier":"53991","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-08-06"}],"displaytype":"detail","filename":"33(3)_123-132.pdf","filesize":[{"value":"826.5 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"33(3)_123-132.pdf","url":"https://niigata-u.repo.nii.ac.jp/record/6699/files/33(3)_123-132.pdf"},"version_id":"8764edce-b8e4-4ec5-aff5-1ad7e74399b8"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Antiplatelet therapy using a combination of dilazep and aspirin in patients with occlusive cerebrovascular diseases","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Antiplatelet therapy using a combination of dilazep and aspirin in patients with occlusive cerebrovascular diseases"},{"subitem_title":"Antiplatelet therapy using a combination of dilazep and aspirin in patients with occlusive cerebrovascular diseases","subitem_title_language":"en"}]},"item_type_id":"7","owner":"1","path":["456","662"],"pubdate":{"attribute_name":"公開日","attribute_value":"2015-10-09"},"publish_date":"2015-10-09","publish_status":"0","recid":"6699","relation_version_is_last":true,"title":["Antiplatelet therapy using a combination of dilazep and aspirin in patients with occlusive cerebrovascular diseases"],"weko_creator_id":"1","weko_shared_id":null},"updated":"2022-12-15T03:40:01.836465+00:00"}